Rx Transparent Compliance Platform Help

DSCSA Exemption Enhancement Feature!

Due to guidance the FDA released dated April 2020 "Exemption and Exclusion from Certain Requirements of the Drug Supply Chain Security Act During the COVID-19 Public Health Emergency," an enhancement feature has been added to Inmar's DSCSA platform.   

This enhancement allows users to identify products that are exempt from DSCSA tracking under these guidelines.  Please access the video tutorial and presentation below that explains this feature enhancement.

DSCSA EXEMPTION Training Video

For customer support call (877) 727-6276 or email rxtsupport@inmar.com

Help Segments:

Incidents

  • Ability to report suspect or damaged product and quantity errors
  • Status: open, under review or closed categories

View Invoices

  • Ability to check in received product
  • Can report incidents and correct quantities

View Pedigrees

  • Ability to view, print or email pedigree with T3 required information

Borrow / Create Pedigrees

  • Ability to report on products that are borrowed from other locations
  • Maintain pedigrees from a manufacturer who does not have EDI capabilities

Trade / Sell / Return

  • Update existing pedigree for trading, selling or returning a product

Reporting

  • Incident Summary
  • Loan Summary
  • Pedigree Summary / Details
  • Recently Viewed Pedigrees

First Responder Resupply Form

  • Create a transaction record for products resupplied to individual EMS/ FD

Administration

  • Destinations – add in owned hospital facilities, trading partners, EMS or update facility information
  • Edit Pedigrees – request to edit a pedigree, will email the RXT support team
  • User Management – shows the users on your account and the last log-in date/time stamped
  • Activity Log – shows the activities on your account, date/time stamped
  • My Account – request to change password, you will receive an email with a link to re-set password
  • Auto-Pilot – the ability to turn on/off the auto check-in process, ability to select the number of days (we suggest 3-4 days)